Immunomodulation of murine collagen-induced arthritis by N, N-dimethylglycine and a preparation of Perna canaliculus

BMC Complementary and Alternative Medicine

Volumn 7, Issue , 2007, Pages

  Lawson, Brian R ^a   Belkowski, Stanley M ^a   Whitesides, John F ^a   Davis, Paul ^b   Lawson, John W ^a  

^a CLEMSON UNIVERSITY   (United States)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

'PERNA'; COLLAGEN TYPE 2; DIMETHYLGLYCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 12P40; LIPOPOLYSACCHARIDE; NATURAL PRODUCT; PERNA CANALICULUS EXTRACT; RHEUMATOID FACTOR; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; COLLAGEN; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; SARCOSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMBINATION CHEMOTHERAPY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INCIDENCE; INFLAMMATION; INHIBITION KINETICS; MONOCYTE; MONOTHERAPY; MOUSE; MUSSEL; NEUTROPHIL; NEW ZEALAND; NONHUMAN; PATHOPHYSIOLOGY; PERNA; RHEUMATOID ARTHRITIS; SPECIES DIFFERENCE; ANIMAL; ARTHRITIS; BONE; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; IMMUNOLOGY; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, EXPERIMENTAL; BONE AND BONES; COLLAGEN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOSUPPRESSIVE AGENTS; MICE; PERNA; RATS; SARCOSINE;

EID: 34347380095     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-7-20     Document Type: Article

References (47)

1. Schroder K Hertzog PJ Ravasi T Hume DA Interferon-gamma: An overview of signals, mechanisms and functions J Leukoc Biol 2004 75 2 163-189 10.1189/jlb.0603252 14525967
2. Hill N Sarvetnick N Cytokines: Promoters and dampeners of autoimmunity. Curr Opin Immunol 2002 14 6 791-797 10.1016/S0952-7915(02)00403-X 12413531
3. Bach JF Cytokine-based immunomodulation of autoimmune diseases: An overview Transplant Proc 1996 28 6 3023-3025 8962173
4. De Maeyer-Guignard J De Maeyer E Immunomodulation by interferons: Recent developments Interferon 1985 6 69-91 3926654
5. Szekeres-Bartho J Barakonyi A Par G Polgar B Palkovics T Szereday L Progesterone as an immunomodulatory molecule Int Immunopharmacol 2001 1 6 1037-1048 10.1016/S1567-5769(01)00035-2 11407300
6. Abo-Zena RA Horwitz ME Immunomodulation in stem-cell transplantation Curr Opin Pharmacol 2002 2 4 452-457 10.1016/S1471-4892(02)00174-1 12127880
7. Roberts CW Satoskar A Alexander J Sex steroids, pregnancy-associated hormones and immunity to parasitic infection Parasitol Today 1996 12 10 382-388 10.1016/0169-4758(96)10060-0 15275288
8. Nizametidinova G Effectiveness of calcium pangamate introduced into vaccinated and X-irradiated animals. Reports of the Kazan Veterinary Institute 1972 112 100-104
9. Graber CD Goust JM Glassman AD Kendall R Loadholt CB Immunomodulating properties of dimethylglycine in humans J Infect Dis 1981 143 1 101-105 6163829
10. Reap EA Lawson JW Stimulation of the immune response by dimethylglycine, a nontoxic metabolite J Lab Clin Med 1990 115 4 481-486 1691258
11. Weiss RC Immunologic responses in healthy random-source cats fed N,N-dimethylglycine-supplemented diets Am J Vet Res 1992 53 5 829-833 1381880
12. Miller TE Dodd J Ormrod DJ Geddes R Anti-inflammatory activity of glycogen extracted from Perna canaliculus (NZ green-lipped mussel) Agents Actions 1993 38 Spec No C139-42 8317309 10.1007/BF01991164
13. Mani S Lawson JW In vitro modulation of inflammatory cytokine and IgG levels by extracts of Perna canaliculus BMC Complement Altern Med 2006 6 1 1388237 16412227 10.1186/1472-6882-6-1
14. Mani S Whitesides JF Lawson JW Use of Perna and Dimethylglycine (DMG) as immunotherapeutic agents in autoimmune diseases and melanoma. Critical Reviews in Biomedical Engineering 2000 25 405
15. Miller TE Wu H In vivo evidence for prostaglandin inhibitory activity in New Zealand green-lipped mussel extract The New Zealand Medical Journal 1984 97 757 355-357 6589519
16. Halpern GM Anti-inflammatory effects of a stabilized lipid extract of Perna canaliculus (Lyprinol) Allerg Immunol (Paris) 2000 32 7 272-278 11094640
17. Kosuge T Tsuji K Ishida H Yamaguchi T Isolation of an anti-histaminic substance from green-lipped mussel (Perna canaliculus) Chem Pharm Bull (Tokyo) 1986 34 11 4825-4828 3829196
18. Hariganesh K Prathiba J Effect of dimethylglycine on gastric ulcers in rats J Pharm Pharmacol 2000 52 12 1519-1522 10.1211/0022357001777568 11197081
19. Kannan K Ortmann RA Kimpel D Animal models of rheumatoid arthritis and their relevance to human disease Pathophysiology 2005 12 3 167-181 10.1016/j.pathophys.2005.07.011 16171986
20. Brand DD Kang AH Rosloniec EF Immunopathogenesis of collagen arthritis Springer Semin Immunopathol 2003 25 1 3-18 10.1007/s00281-003-0127-1 12904888
21. Tan AS Berridge MV Superoxide produced by activated neutrophils efficiently reduces the tetrazolium salt, WST-1 to produce a soluble formazan: A simple colorimetric assay for measuring respiratory burst activation and for screening anti-inflammatory agents J Immunol Methods 2000 238 1 2 59-68 10.1016/S0022-1759(00)00156-3 10758236
22. Nordling C Holmdahl R Klareskog L A monoclonal antiidiotypic antibody with rheumatoid factor activity defines a cross-reactive idiotope on murine anticollagen antibodies J Immunol 1991 146 12 4258-4263 1710245
23. Ulmansky R Naparstek Y Immunoglobulins from rats that are resistant to adjuvant arthritis suppress the disease in arthritis-susceptible rats Eur J Immunol 1995 25 4 952-957 10.1002/eji.1830250415 7737299
24. Cobb CS Ernst E Systematic review of a marine nutriceutical supplement in clinical trials for arthritis: The effectiveness of the New Zealand green-lipped mussel Perna canaliculus Clin Rheumatol 2006 25 3 275-284 10.1007/s10067-005-0001-8 16220229
25. Bierer TL Bui LM Improvement of arthritic signs in dogs fed green-lipped mussel (Perna canaliculus) J Nutr 2002 132 6 Suppl 2 1634S-6S 12042477
26. Bui LM Bierer TL Influenece of green-lipped mussels (Perna canaliculus) in alleviating signs of arthritis in dogs. Veterinary Therapeutics 2003 4 4 397-407 15136981
27. Caughey DE Grigor RR Caughey EB Young P Gow PJ Stewart AW Perna canaliculus in the treatment of rheumatoid arthritis Eur J Rheumatol Inflamm 1983 6 2 197-200 6673984
28. Gibson RG Gibson SL Conway V Chappell D Perna canaliculus in the treatment of arthritis Practitioner 1980 224 1347 955-960 7003577
29. Gibson SLM Gibson RG The treatment of arthritis with a lipid extract of Perna canaliculus: A randomized trial. Complimentary Therapies in Medicine 1998 6 122 10.1016/S0965-2299(98)80003-4
30. Miller TE Ormrod D The anti-inflammatory activity of Perna canaliculus (NZ green lipped mussel) The New Zealand Medical Journal 1980 92 667 187-193 6933356
31. Feldmann M Brennan FM Maini RN Role of cytokines in rheumatoid arthritis Annu Rev Immunol 1996 14 397-440 10.1146/annurev.immunol.14.1.397 8717520
32. Feldmann M Maini RN Anti-TNF alpha therapy of rheumatoid arthritis: What have we learned? Annu Rev Immunol 2001 19 163-196 10.1146/ annurev.immunol.19.1.163 11244034
33. Breedveld FC [Tumour necrosis factor antagonists: Infliximab, adalimumab and etanercept] Ned Tijdschr Geneeskd 2005 149 41 2273-2277 16240851
34. Macias I Garcia-Perez S Ruiz-Tudela M Medina F Chozas N Giron-Gonzalez JA Modification of pro- and antiinflammatory cytokines and vascular-related molecules by tumor necrosis factor-a blockade in patients with rheumatoid arthritis J Rheumatol 2005 32 11 2102-2108 16265686
35. Di Giovine FS Nuki G Duff GW Tumour necrosis factor in synovial exudates Ann Rheum Dis 1988 47 9 768-772 1003595 3263088
36. Saxne T Palladino MA Jr. Heinegard D Talal N Wollheim FA Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum Arthritis Rheum 1988 31 8 1041-1045 10.1002/art.1780310816 3136775
37. Brennan FM Gibbons DL Mitchell T Cope AP Maini RN Feldmann M Enhanced expression of tumor necrosis factor receptor mRNA and protein in mononuclear cells isolated from rheumatoid arthritis synovial joints Eur J Immunol 1992 22 7 1907-1912 10.1002/eji.1830220734 1320571
38. Buchan G Barrett K Turner M Chantry D Maini RN Feldmann M Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha Clin Exp Immunol 1988 73 3 449-455 3264773
39. Firestein GS Alvaro-Gracia JM Maki R Quantitative analysis of cytokine gene expression in rheumatoid arthritis J Immunol 1990 144 9 3347-3353 2109776
40. Cooper WO Fava RA Gates CA Cremer MA Townes AS Acceleration of onset of collagen-induced arthritis by intra-articular injection of tumour necrosis factor or transforming growth factor-beta Clin Exp Immunol 1992 89 2 244-250 1638767
41. Brahn E Peacock DJ Banquerigo ML Liu DY Effects of tumor necrosis factor alpha (TNF-alpha) on collagen arthritis Lymphokine Cytokine Res 1992 11 5 253-256 1467365
42. Thorbecke GJ Shah R Leu CH Kuruvilla AP Hardison AM Palladino MA Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice Proc Natl Acad Sci U S A 1992 89 16 7375-7379 49712 1502148 10.1073/ pnas.89.16.7375
43. Piguet PF Grau GE Vesin C Loetscher H Gentz R Lesslauer W Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor Immunology 1992 77 4 510-514 1421669 1337334
44. Williams RO Feldmann M Maini RN Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis Proc Natl Acad Sci U S A 1992 89 20 9784-9788 50217 1409699 10.1073/pnas.89.20.9784
45. Wooley PH Dutcher J Widmer MB Gillis S Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice J Immunol 1993 151 11 6602-6607 8245488
46. Williams RO Ghrayeb J Feldmann M Maini RN Successful therapy of collagen-induced arthritis with TNF receptor-IgG fusion protein and combination with anti-CD4 Immunology 1995 84 3 433-439 1415129 7751027
47. Mengle-Gaw LJ Schwartz BD Cyclooxygenase-2 inhibitors: Promise or peril? Mediators Inflamm 2002 11 5 275-286 1781678 12467519 10.1080/ 09629350290000041